There are 594 resources available
42P - First-line (1L) nivolumab (N) + ipilimumab (I) with 2 cycles of platinum-based chemotherapy (C) in patients (pts) with metastatic non-small cell lung cancer (mNSCLC): Interim data from the German non-interventional study (NIS) FINN
Presenter: Christian Schumann
Session: Poster Display session
43P - Phase Ia study of MIDRIX4-LUNG, a tetravalent autologous dendritic cell immunotherapy, in patients with metastatic non-small cell lung cancer
Presenter: Dieter Stevens
Session: Poster Display session
44P - First-line chemo-immunotherapy prognostic factors predicting non-small cell lung cancer (NSCLC) overall survival: Multicentric observational study
Presenter: Riccardo Ronga
Session: Poster Display session
45P - Extended follow-up confirmed real-world efficacy and safety of cemiplimab monotherapy in advanced non-small cell lung cancer (NSCLC) with high PD-L1 expression
Presenter: Silvia Masini
Session: Poster Display session
46P - Comparison of camrelizumab, pembrolizumab, tislelizumab, and sintilimab as first-line treatment in patients with non-small cell lung cancer: A retrospective study
Presenter: Shaorong Yu
Session: Poster Display session
47P - Efficacy and safety of cadonilimab-based therapies in non-small cell lung cancer patients with progression after immunotherapy
Presenter: Shaorong Yu
Session: Poster Display session
48P - Real-world evaluation of ipilimumab (Ipi)/nivolumab (Nivo) in combination with two cycles of chemotherapy in patients (pts) with programmed death-ligand (PD-L1) negative advanced non-small cell lung cancer (aNSCLC): Interim results of the RW-9LA study
Presenter: Lore Decoster
Session: Poster Display session
49P - Phase II study of telomere-targeting agent THIO sequenced by cemiplimab in immune checkpoint inhibitor-resistant advanced NSCLC: Interleukin-6 as a potential predictive biomarker
Presenter: Tomasz Jankowski
Session: Poster Display session
50P - The impact of prior bevacizumab on the efficacy of anlotinib in advanced non-squamous non-small cell lung cancer
Presenter: jiale Wang
Session: Poster Display session
51P - Impact of body mass index on immunotherapy outcomes and survival in advanced NSCLC
Presenter: Walid Shalata
Session: Poster Display session